Danaher Corporation $DHR Shares Bought by Danica Pension Livsforsikringsaktieselskab

Danica Pension Livsforsikringsaktieselskab lifted its position in shares of Danaher Corporation (NYSE:DHR) by 10.5% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 241,879 shares of the conglomerate’s stock after buying an additional 22,967 shares during the quarter. Danaher makes up 0.9% of Danica Pension Livsforsikringsaktieselskab’s investment portfolio, making the stock its 27th largest position. Danica Pension Livsforsikringsaktieselskab’s holdings in Danaher were worth $45,860,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Main Street Group LTD purchased a new position in shares of Danaher during the first quarter valued at approximately $25,000. JPL Wealth Management LLC purchased a new stake in Danaher in the 3rd quarter worth approximately $25,000. Elevated Capital Advisors LLC purchased a new stake in Danaher in the 4th quarter worth approximately $26,000. WFA of San Diego LLC acquired a new position in Danaher in the 2nd quarter valued at $26,000. Finally, Hilton Head Capital Partners LLC acquired a new position in Danaher in the 4th quarter valued at $27,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Down 11.0%

Shares of NYSE DHR opened at $179.01 on Wednesday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The firm has a fifty day moving average of $184.22 and a 200-day moving average of $197.69. The stock has a market capitalization of $126.70 billion, a PE ratio of 34.62, a P/E/G ratio of 2.48 and a beta of 0.79. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, July 21st. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.84 by $0.10. The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.11 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.77 EPS. On average, analysts anticipate that Danaher Corporation will post 8.45 EPS for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio is currently 30.95%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on DHR. Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. The Goldman Sachs Group dropped their target price on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Monday, April 13th. HSBC reduced their target price on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. DZ Bank initiated coverage on Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price target for the company. Finally, Wells Fargo & Company dropped their price objective on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $231.64.

Trending Headlines about Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher posted Q2 adjusted EPS of $1.94, above the $1.84 consensus, and revenue of about $6.26 billion to $6.3 billion, also ahead of estimates. Danaher Reports Second Quarter 2026 Results
• Positive Sentiment: Management raised full-year adjusted EPS guidance, showing confidence in profitability despite the softer sales backdrop. Danaher Corp (DHR) Q2 2026 Earnings Call Highlights
• Neutral Sentiment: Life Sciences was a bright spot, with stronger sales growth, but bioprocessing revenue came in weaker than expected and was cited as a drag on sentiment. Reuters: Danaher’s revenue outlook cut, biotech miss overshadow profit forecast raise
• Negative Sentiment: Investors reacted negatively to the reduced core revenue growth outlook and cautious near-term guidance, which outweighed the earnings beat and led to the stock decline. Danaher stock slips despite Q2 earnings beat, raised guidance
• Negative Sentiment: Analysts also highlighted “surprisingly soft” bioprocessing sales, reinforcing concerns that growth may slow more than expected. Danaher Plummets After One Segment Comes In ‘Surprisingly Soft’

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.